NicolaHananiaMDMS

PubMed

• An Update on Patient-Reported Outcomes in Asthma.
  Tianshi David Wu, Zuzana Diamant, Nicola A Hanania> ;Chest. 2024 Feb 15
• Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.
  Brusselle, G., Sun, L., Siu, K., Wu, W., Corren, J., Szefler, S., Sher, E., Korenblat, P., Soong, W., Hanania, N., Berman, G., Zitnik, R., Natalie, C., Lio, P., Armstr...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Feb 14
• Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020-2023.
  Maria Gabriella Matera, Luigino Calzetta, Paola Rogliani, Nicola Hanania, Mario Cazzola> ;Lung. 2024 Apr 1
• Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.
  Chase, N., Littlejohn, M., Holweg, C., Millette, L., Seetasith, A., Steinke, J., Trzaskoma, B., Hanania, N., Casale, T.> ;Respiratory Medicine. 2024 Mar 1
• 1 citations
  Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations.
  Regan, E., Lowe, M., Make, B., Curtis, J., Chen, Q., Crooks, J., Wilson, C., Oates, G., Gregg, R., Baldomero, A., Bhatt, S., Diaz, A., Benos, P., O'Brien, J., Young, K...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Jan 1
• Tezepelumab in patients with allergic and eosinophilic asthma.
  Caminati, M., Buhl, R., Kim, H., Korn, S., Lommatzsch, M., Martin, N., Matucci, A., Nasser, S., Pavord, I., Domingo, C., Corren, J., Hanania, N.> ;Allergy. 2023 Dec 26
• Influence of baseline bronchodilator reversibility and blood eosinophils on lung function in patients with asthma following omalizumab.
  Thomas B Casale, Bradley E Chipps, Ahmar Iqbal, Bongin Yoo, Lauren A Millette, Nicola A Hanania> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Feb 1
• Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection.
  Wallick, C., To, T., Korom, S., Masters, H., Wu, N., Moawad, D., Hanania, N.> ;Influenza and Other Respiratory Viruses. 2023 Dec 1
• 1 citations
  Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization.
  Nicola A Hanania, Russell A Settipane, Samir Khoury, Asif Shaikh, Zenobia Dotiwala, Julian Casciano, Michael B Foggs> ;Allergy and Asthma Proceedings. 2023 Nov 13
• Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants.
  Bhatt, S. P., Edwin K Silverman, Arthur Y Kim, Barry J Make, Elizabeth A Regan, Jarrett D Morrow, Craig P Hersh, James O'Brien, James D Crapo, Nadia N Hansel, Gerard C...> ;NPJ Genomic Medicine. 2023 Oct 31
• Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study.
  Bhatt, S. P., Regan, E., Lowe, M., Make, B., Curtis, J., Chen, Q., Cho, M., Crooks, J., Lowe, K., Wilson, C., O'Brien, J., Oates, G., Baldomero, A., Kinney, G., Young,...> ;Journal of General Internal Medicine. 2023 Oct 1
• 3 citations
  Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
  Linda Rogers, Milos Jesenak, Leif Bjermer, Nicola A Hanania, Sven F Seys, Zuzana Diamant> ;Respiratory Medicine. 2023 Nov 1
• Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.
  Jonathan Corren, Nicola A Hanania, William W Busse, Lawrence D Sher, Arman Altincatal, Megan Hardin, Leda P Mannent, Nikhil Amin, David J Lederer, Xavier Soler, Juby A...> ;Clinical and Experimental Allergy. 2023 Oct 1
• 1 citations
  Asthma in the era of COVID-19.
  Sara Assaf, Henning Stenberg, Milos Jesenak, Svitlana P Tarasevych, Nicola A Hanania, Zuzana Diamant> ;Respiratory Medicine. 2023 Nov 1
• Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer?
  Muhammad Adrish, Nicola A Hanania> ;American Journal of Respiratory and Critical Care Medicine. 2023 Sep 1
• 1 citations
  Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program.
  Margee Kerr, Yasir Tarabichi, Alexander Evans, Douglas Mapel, Wilson Pace, Victoria Carter, Amy Couper, M Bradley Drummond, Norbert Feigler, Alex Federman, Hitesh Gand...> ;Lancet Regional Health. Americas. 2023 Aug 1
• EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and...
  Zuzana Diamant, Milos Jesenak, Nicola A Hanania, Liam G Heaney, Ratko Djukanovic, Dermot Ryan, Santiago Quirce, Vibeke Backer, Mina Gaga, Ian Pavord, Darío Antolín-Amé...> ;Respiratory Medicine. 2023 Nov 1
• 4 citations
  Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?
  Mario Cazzola, Clive P Page, Maria Gabriella Matera, Paola Rogliani, Nicola A Hanania> ;The European Respiratory Journal. 2023 Aug 1
• Integrating innovations in asthma research into clinical practice.
  Zuzana Diamant, Sven F Seys, Linda Rogers, Nicola A Hanania> ;Respiratory Medicine. 2023 Oct 1
• 1 citations
  Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma.
  John Oppenheimer, Nicola A Hanania, Rekha Chaudhuri, Hironori Sagara, Zelie Bailes, Andrew Fowler, Guy Peachey, Emilio Pizzichini, David Slade> ;Chest. 2023 Nov 1
• 2 citations
  Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities.
  Maria Gabriella Matera, Nicola A Hanania, Mauro Maniscalco, Mario Cazzola> ;Drugs & Aging. 2023 Jul 1
• 1 citations
  Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022.
  Daiana Stolz, Maria Gabriella Matera, Paola Rogliani, Maarten van den Berge, Eleni Papakonstantinou, Reinoud Gosens, Dave Singh, Nicola Hanania, Mario Cazzola, Anke-Hi...> ;Breathe. 2023 Jun 1
• 1 citations
  An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society St...
  Mario Cazzola, Paola Rogliani, Peter J Barnes, Francesco Blasi, Bartolome Celli, Nicola A Hanania, Fernando J Martinez, Bruce E Miller, Marc Miravitlles, Clive P Page,...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Aug 15
• 11 citations
  New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.
  Ilja Striz, Kornel Golebski, Zuzana Strizova, Stelios Loukides, Petros Bakakos, Nicola A Hanania, Milos Jesenak, Zuzana Diamant> ;Clinical Science. 2023 May 18
• 6 citations
  Update on the Role of FeNO in Asthma Management.
  Neveda Murugesan, Damini Saxena, Arundhati Dileep, Muhammad Adrish, Nicola A Hanania> ;Diagnostics. 2023 Apr 15
• Join now to see all

Journal Articles

• Care Pathways for the Selection of a Biologic in Severe Asthma  
  Michael E Wechsler, Wanda Phipatanakul, Nicola A Hanania, The European Respiratory Journal
• Executive summary: prevention of acuteexacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline  
  Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, FielSB, Forem..., Chest, 1/1/2015
• The Saudi guidelines for chronic obstructive pulmonary disease: A fresh "Real-World" approach to COPD  
  Hanania NA, Ann Thorac Med, 1/1/2014
• Blocking KV13 channels inhibits Th2 lymphocyte function and treats a rat model of asthma  
  Koshy S, Huq R, Tanner MR, Atik MA, Porter PC, Khan FS, Pennington MW, Hanania NA, Corry DB, Beeton C, J Biol Chem, 1/1/2014
• The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management  
  E.A. Lancet, J. T. Holbrook, R.A. Wise, NA Hanania, Clin. Invest., 1/1/2014
• Omalizumab in asthma: an update on recent developments  
  Humbert M, Busse W, Hanania NA, Lowe PJ, Canvin J, Erpenbeck VJ, Holgate S, J Allergy Clin Immunol Pract, 1/1/2014
• Optimizing safety of COPD treatments: role of the nurse practitioner  
  Spencer P, Hanania NA, J Multidiscip Healthc, 1/1/2013
• The safety of long-acting beta2-agonists in the treatment of stable chronic obstructive pulmonary disease  
  Decramer ML, Hanania NA, Lotvall JO, Yawn BP, Int J Chron Obstruct Pulmon Dis, 1/1/2013
• Ten years of tiotropium: clinical impact and patient perspectives  
  Yohannes AM, Connolly MJ, Hanania NA, Int J Chron Obstruct Pulmon Dis, 1/1/2013
• Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility  
  Siedlinski M, Tingley D, Lipman PJ, Cho MH, Litonjua AA, Sparrow D, Bakke P, Gulsvik A, Lomas DA, Anderson W, Kong X, Rennard SI, Beaty TH, Hokanson JE, Crapo JD, Lang..., Hum Genet, 1/1/2013
• Age-related differences in asthma outcomes in the United States, 1988-2006  
  Tsai CL, Delclos GL, Huang JS, Hanania NA, Camargo CA Jr, Ann Allergy Asthma Immunol, 1/1/2013
• Exploring the effects of omalizumab in allergic asthma  
  Hanania NA, Wenzel S, Rosen K, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse W, Am J Respir Crit Care Med, 1/1/2013
• Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, rando...  
  Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Vestbo J, Wachtel A, Martinez FJ, Barnhart F, Sanford L, Lettis S, Crim C, Calverley PMA, Lancet Respir Med, 1/1/2013
• Evaluating the safety of COPD medications: an evidence-based review  
  Hanania NA, Chest, 1/1/2013
• Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma  
  Wechsler ME, Laviolette M, Rubin AS, Fiterman J, Lapa E Silva JR, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM, Pavord ID, Simoff M, Hales JB, McEvoy C, Slebos..., J Allergy Clin Immunol, 1/1/2013
• Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults  
  Zach JA, Newell JD Jr, Schroeder J, Murphy JR, Curran-Everett D, Hoffman EA, Westgate PM, Han MK, Silverman EK, Crapo JD, Lynch DA; COPDGene Investigators (Hanania NA), Invest Radiol, 1/1/2012
• Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide  
  Hanania NA, Respir Med, 1/1/2012
• Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease  
  Kim DK, Cho MH, Hersh CP, Lomas DA, Miller BE, Kong X, Bakke P, Gulsvik A, Agustí A, Wouters E, Celli B, Coxson H, Vestbo J, MacNee W, Yates JC, Rennard S, Litonjua A,..., Am J Respir Crit Care Med, 1/1/2012
• A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation  
  COPDGene CT Workshop Group, Barr RG, Berkowitz EA, Bigazzi F, Bode F, Bon J, Bowler RP, Chiles C, Crapo JD, Criner GJ, Curtis JL, Dass C, Dirksen A, Dransfield MT, Edu..., COPD, 1/1/2012
• Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008  
  Tsai CL, Lee WY, Hanania NA, Camargo CA Jr, J Allergy Clin Immunol, 1/1/2012
• New bronchodilators  
  Mak G, Hanania NA, Curr Opin Pharmacol, 1/1/2012
• Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype  
  Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, M..., PLoS One, 1/1/2012
• Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease  
  Martinez CH, Chen YH, Westgate PM, Liu LX, Murray S, Curtis JL, Make BJ, Kazerooni EA, Lynch DA, Marchetti N, Washko GR, Martinez FJ, Han MK; COPDGene Investigators (H..., Thorax, 1/1/2012
• Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications  
  Sumino K, Sugar EA, Irvin CG, Kaminsky DA, Shade D, Wei CY, Holbrook JT, Wise RA, Castro M; American Lung Association Asthma Clinical Research Centers (Hanania NA), J Allergy Clin Immunol, 1/1/2012
• The efficacy and safety of the novel long-acting beta2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial  
  Hanania NA, Feldman G, Zachgo W, Shim JJ, Crim C, Sanford L, Lettis S, Barnhart F, Haumann B, Chest, 1/1/2012
• Join now to see all

Books/Book Chapters

• Advances in Geroscience 
  Chapter: Aging and Asthma 
  Hanania NA, Busse PEditors: Sierra F and Kohanski RA.Springer2015
• Gastroesophageal Reflux and the Lung 
  Chapter: GER in Asthma and COPD 
  Akkanti B, Hanania NAEditors: Meyer KC and Raghu G.Humana Press2013
• COPD: Clinical Guide for the Diagnosis and Management 
  Editors: Hanania NA, Sharafkhaneh A.Springer2011
• COPD: Clinical Guide for the Diagnosis and Management 
  Chapter: Pharmacologic Therapy: Bronchodilators 
  Hanania NA, Cazzola MEditors: Hanania NA and Sharafkhaneh AS.Humana Press2011
• Conn’s Current Therapy 
  Chapter: COPD 
  Hanania NA, Sharafkhaneh AEditors: Bope ET, Kellerman RD.Elsevier Saunders2011
• Critical Care Obstetrics 
  Chapter: Acute lung injury and acute respiratory distress (ARDS) during pregnancy 
  Mallampalli A, Hanania NA, Guntupalli KKEditors: Belfort MA, Saade G, Foley MR, Phelan JP, Dildy GA.Blackwell Publishing LimitedEdition 5th,2010
• Atlas of COPD 
  Chapter: Comorbidities of chronic obstructive pulmonary disease 
  Kao C, Hanania NAEditors: Crapo JD.Springer2009
• Therapeutic strategies for Acute COPD Exacerbations 
  Chapter: Future pharmacologic therapy of exacerbations in COPD 
  Hanania NA, Sharafkhaneh ASEditors: Cazzola M, Sethi S, Blasi F, Anzueto A.Clinical Publishing, Oxford2009
• Clinical Asthma 
  Chapter: Bronchodilators: Beta2-agonists and anticholinergics 
  Hanania NA, Cazzola MEditors: Castro M, Kraft M.Mosby Elsevier2008
• Therapeutic Strategies Asthma Current Treatments 
  Chapter: Non-bronchodilator activities of Beta2- agonists 
  Hanania NAEditors: Polosa R, Holgate ST.Clinical Publishing, Oxford2007
• Principles of Critical Care 
  Chapter: Hypothermia 
  Hanania NA, Zimmerman JLEditors: Hall, Schmidt, Wood.McGraw Hill2004
• Tuberculosis 
  Chapter: Endobronchial Tuberculosis 
  Dhillon S, Hanania NAEditors: Sharma.Edition 3rd,2004
• Saunders Manual of Critical Care 
  Chapter: Hypothermia 
  Page 525.0 - 530.0Hanania NAEditors: Kruse JA, Fink MP, Carlson RW.Saunders, Elsevier Science2003
• Environmental Emergencies 
  Editors: Hanania NA.Critical Care Clinics1999
• Join now to see all

Abstracts/Posters

• Efficacy and safety of lebrikizumab in severe uncontrolled asthma: Results from the lute and verse phase II randomized, double-blind, placebo-controlled trials
  Hanania NA, et al, AAAAI, 1/1/2014
• Characteristics Of Elderly And Younger Patients With COPD In The COPDgene Cohort
  A. D. Parulekar, C.-L. Tsai, M. A. Atik, H. Al-Azzawi, A. F. Mohsin, A. Sharafkhaneh, D. L. DeMeo, E. A. Regan, B. J. Make, N. A. Hanania, COPDGene Study Group, Am J Respir Crit Care Med, 1/1/2014
• Characteristics Of Previously Undiagnosed COPD In The COPDgene Cohort
  A. D. Parulekar, M. A. Atik, D. C. Everett, M. S. Gozegir, A. F. Mohsin, E. A. Regan, R. A. Wise, B. J. Make, A. Sharafkhaneh, N. A. Hanania, COPDGene Study Group, Am J Respir Crit Care Med, 1/1/2014
• Factors Affecting Mortality In Very Elderly Patients With Chronic Obstructive Pulmonary Disease (COPD): Results From COVAD (COPD Outcomes From VA Database) Study
  M. B. Nair, A. Spiegelman, N. A. Hanania, A. Sharafkhaneh, Am J Respir Crit Care Med, 1/1/2014
• Impact Of Initiating Nebulized Formoterol Fumarate On Health Outcomes In COPD Patients Who Frequently Use Short-Acting Inhaled beta2-Agonists
  G. Colice, A. Buikema, L. Xie, A. Sharafkhaneh, R. Rodiguez-Roisin, N. Hanania, A. Altman, J. R. Harper, O. Baser, P. Altman, Am J Respir Crit Care Med, 1/1/2014
• A Long Term Safety Study Of Arformoterol Tartrate In The Maintenance Therapy Of Patients With Moderate To Severe COPD: Incidence Of Adverse Events
  N. A. Hanania, J. F. Donohue, B. J. Make, Am J Respir Crit Care Med, 1/1/2013
• Total Mortality Decreased In Last Decade In Patients With Clinical Diagnosis Of COPD
  H. Qureshi, A. Spiegelman, N. A. Hanania, A. Sharafkhaneh, Am J Respir Crit Care Med, 1/1/2013
• A Long Term Safety Study Of Arformoterol Tartrate In The Maintenance Therapy Of Patients With Moderate To Severe COPD: Evaluation Of Lung Function
  B. J. Make, N. A. Hanania, J. F. Donohue, Am J Respir Crit Care Med, 1/1/2013
• A Long Term Safety Study Of Arformoterol Tartrate In The Maintenance Therapy Of Patients With Moderate To Severe COPD: Incidence Of Respiratory-Related Deaths And COPD...
  J. F. Donohue, N. A. Hanania, B. J. Make, L. Curry, Am J Respir Crit Care Med, 1/1/2013
• A Simplified Severity Staging System For Chronic Obstructive Pulmonary Disease
  W. Checkley, M. G. Foreman, S. P. Bhatt, M. T. Dransfield, M. K. Han, N. A. Hanania, N. Hansel, E. Regan, R. A. Wise, COPDGene Investigators, Am J Respir Crit Care Med, 1/1/2013
• Effect Of Fluticasone Furoate (ff)/vilanterol (vi) Compared With Vi On COPD Exacerbations: A Pre-Specified Subgroup Analysis
  M. T. Dransfield, P. M. Calverley, J. Bourbeau, P. W. Jones, N. A. Hanania, D. A. Mahler, J. Vestbo, A. Wachtel, F. J. Martinez, F. Barnhart, D. Midwinter, S. Lettis, ..., Am J Respir Crit Care Med, 1/1/2013
• Comorbid Diseases In COPD Impacts Exercise Capacity, Quality Of Life And Dyspnea
  N. Putcha, N. Hansel, C. H. Martinez, M. K. Han, A. E. Williams, C. P. Hersh, R. A. Wise, B. M. Thomashow, N. A. Hanania, R. Casaburi, G. L. Kinney, Y.-I. Kim, G. R. W..., Am J Respir Crit Care Med, 1/1/2013
• A Large Simple Safety Study of Nebulized Arformoterol Tartrate: Incidence and Risk of Protocol-Defined COPD Exacerbations
  N.A. Hanania, J. Donohue, B. Make, Chest, 1/1/2013
• Improved Health Related Quality of Life Outcomes in Subjects With Moderate to Severe COPD Treated With Nebulized Arformoterol Tartrate: Results From a 52-Week Trial
  J. Donohue, V. Bollu, N.A. Hanania, Chest, 1/1/2013
• A Large Simple Safety Study of Nebulized Arformoterol Tartrate: Risk of Respiratory-Related Deaths and COPD Exacerbation-Related hospitalizations by Smoking Status, Ag...
  J. Donohue, N. A. Hanania, B. Make, Chest, 1/1/2013
• Safety of fluticasone furoate (FF), an inhaled corticosteroid in combination with vilanterol (VI), a long-acting beta agonist in management of COPD exacerbations
  P.M.A. Calverley, M. T. Dransfield, J.Bourbeau, P. Jones, N. A. Hanania, D. A. Mahler, J. Vestbo, A. Wachtel, F. Martinez, F. Barnhart, L. Sanford, S. Lettis, C. Crim, Eur Respir J, 1/1/2012
• Efficacy of the novel inhaled corticosteroid, fluticasone furoate (FF)/long-acting beta2-agonist, vilanterol (VI) combination in reducing COPD exacerbations
  M. T. Dransfield, P. M.A.C. Calverley, J. Bourbeau, P. Jones, N.A. Hanania, D. A. Mahler, J. Vestbo, A. Wachtel, F. Martinez, F. Barnhart, L. Sanford, S. Lettis, C.C. ..., Eur Respir J, 1/1/2012
• Efficacy And Safety Of Roflumilast From The Pivotal Studies In The North American Patient Population
  N. A. Hanania, J. P. Karpel, U.-M. Goehring, M. Brose, D. Bredenbroker, H. Lakkis, P. Rowe, F. J. Martinez, Am J Respir Crit Care Med, 1/1/2012
• Age-Related Differences In The Presentation And Outcomes Of Acute Asthma In The United States, 2006-2008
  C.-L. Tsai, W.-Y. Lee, N. A. Hanania, C. Camargo, Am J Respir Crit Care Med, 1/1/2012
• G. T. Ferguson, S. I. Rennard, N. A. Hanania, H. Zhu, S. Siddiqui, H. Sacks, P. Rowe, Am J Respir Crit Care Med, 1/1/2012
• A Simple Rule To Identify COPD Patients Who May Need Treatment Re-Evaluation Based On SABA Use
  A. Sharafkhaneh, N. A. Hanania, G. L. Colice, J. D. Donahue, A. Altan Riedel, J. Kurlander, P. R. Altman, Am J Respir Crit Care Med, 1/1/2012
• Efficacy Of Roflumilast In COPD Patients With Previous Inhaled Corticosteroid And Concomitant Long-Acting beta2-Agonist Treatment
  M. T. Dransfield, N. A. Hanania, U.-M. Goehring, D. Bredenbroker, H. Lakkis, H. Zhu, P. Rowe, P. M. Calverley, Am J Respir Crit Care Med, 1/1/2012
• Lebrikizumab, An Anti-Il-13 Monoclonal Antibody, Reduces Severe Asthma Exacerbations Over 32 Weeks In Adults With Inadequately Controlled Asthma
  D. McClintock, J. Corren, N. A. Hanania, S. Mosesova, P. Lal, J. R. Arron, M. D. Eisner, J. G. Matthews, Am J Respir Crit Care Med, 1/1/2012
• Treatment With Formoterol Fumarate Inhalation Solution (FFIS) Among COPD Patients With High Use of Nebulized Short Acting Beta 2-Agonists (SABAs)
  A.Sharafkhaneh, N.A Hanania, G. Colice, J.Donohue, A. Riedel, J. Kurlander, P. Mastoridis, P. Altman, Chest, 1/1/2012
• Respiratory-Associated Adverse Events in the Roflumilast COPD Safety Pool
  G. Ferguson, N.A.Hanania, U.Goehring, H. Mosberg, M. Brose, D. Bredenbroker, H. Lakkis, P. Rowe, Chest, 1/1/2012
• Join now to see all

Lectures

• COPD: A new look at an old disease 
  Yale University, New Haven, CT - 1/1/2005
• An update on COPD 
  Hartford, CT - 1/1/2005
• Achieving Asthma Control 
  Baltimore, MD - 1/1/2005
• Managing COPD 
  Hunt, Texas - 1/1/2005
• Ventilator- Associated Pneumonia 
  San Antonio, Texas - 1/1/2005
• Indoor Air and Asthma 
  Orlando, FL - 1/1/2004
• SIIVA substudies 
  Orlando, FL - 1/1/2004
• The role of formoterol in acute asthma 
  Chicago, IL - 1/1/2004
• Update on Community Acquired Pneumonia 
  Houston, TX - 1/1/2000
• Ozone and Asthma 
  San Francisco, CA - 1/1/2000
• Frontline Management of COPD 
  Beaumont, Texas - 1/1/1999
• Ozone Related Health Issues 
  Houston, Texas - 1/1/1999
• The use of Beta-agonists in Asthma and COPD 
  Humble, Texas - 1/1/1999
• Use of intravenous immunoglobulins in asthma 
  1/1/1999
• Introduction to Clinical Medicine Course: Management of Asthma and COPD 
  1/1/1999
• Acute Respiratory Failure: Asthma Module 
  1/1/1999
• Multi disciplinary Care of the Pulmonary Patient, Treatment Options in COPD 
  1/1/1998
• Asthma and Pulmonary Disease Update for Primary Care Provider 
  Mission, Texas - 1/1/1998
• NIH Guidelines for Asthma 
  Mission, Texas - 1/1/1998
• Prevention and Control: Role of Anti-inflammatory Drugs 
  Mission, Texas - 1/1/1998
• COPD and Smoking Cessation 
  Houston, Texas - 1/1/1998
• Use of Long-acting B-agonists in the Management of Asthma 
  Houston, Texas - 1/1/1998
• Pulmonary Physiology 
  University of Texas, School of Public Health - 1/1/1998
• Pulmonary Medicine 
  Houston, Texas - 1/1/1998
• Asthma and Allergic Rhinitis Update for The Primary Care Provider 
  Houston, Texas - 1/1/1998
• Join now to see all

Other

• Measures of success for treatment of chronic obstructive pulmonary disease 
  Hanania NA, Medscape CME article
  www.medscape.com
  1/1/2004
• Update on the pharmacologic management of COPD 
  Hanania NA, Medscape CME article
  www.medscape.com
  1/1/2004
• Experto en asma dicta charlas en Puerto Rico 
  Hanania NA
  www.consalud.com
  1/1/2004
• COPD in African Americans 
  Hanania NA
  Baylor College of Medicine Healthline - 1/1/2004
• Expert interview: Treatment of chronic obstructive pulmonary disease. A changing paradigm 
  Hanania NA, An expert interview with Nicola A. Hanania, MD, FCCP, Medscape article
  www.medscape.com
  1/1/2003
• FDA alerts asthmatics to drug safety 
  Hanania NA, Nature Reviews: Drug Discovery, News article
  1/1/2003
• Emphysema in women 
  Hanania NA, Baylor Healthline
  1/1/2003
• Inhaled glucocorticoids as monotherapy in asthma 
  Agrawal A, Hanania NA, Harrison’s Online
  1/1/2002
• Add-on therapy for asthma: leukotriene modifiers vs. long-acting beta2-agonists 
  Hanania NA, Castro M, Harrison’s Online
  1/1/2002
• Asthma and heartburn 
  Hanania NA, Baylor Healthline
  1/1/2002
• Taking asthma medications every day 
  Hanania NA, Baylor Healthline
  1/1/2002
• Ask the Doctor: COPD 
  Hanania NA, Easy Dose it Gazette, American Lung Association of Texas
  1/1/2001
• 5 Myths about air pollution in the Houston Region – that could be costing us our lives 
  Hanania NA, American Lung Association, Houston and Southeast Texas Region (Newspaper/Print Feature)
  1/1/2001
• Smoking and COPD 
  Hanania NA, Baylor Healthline
  1/1/2001
• Ozone and Asthma 
  Hanania NA, Baylor Healthline
  1/1/2001
• Influenza vaccinations in patients with asthma 
  Hanania NA, Baylor Healthline
  1/1/2000
• Asthma in the African Americans 
  Hanania NA, Baylor Healthline
  1/1/2000
• Children are at high risk of exposure to high levels of ozone 
  Hanania NA, Texas Medical Center News
  1/1/1998
• Community Acquired Pneumonia 
  Hanania NA, Baylor Health Channel
  1/1/1998
• Managing Asthma in the Elderly 
  Hanania NA, RT Magazine
  1/1/1997
• Chronic Obstructive Pulmonary Disease: Current Issue in Management 
  Hanania NA, PeerView CME
  www.peerviewpress.com
  University of Florida - 1/6./2004
• New guidelines summarize treatments for COPD 
  Hanania NA, Reuters Health
  1/25/2004
• Group reports city’s air plagued more by ozone than particles 
  Hanania NA, Houston Chronicle
  1/29/2004
• Distant fires darken skies, raise health concerns 
  Hanania NA, Houston Chronicle
  1/8./2003
• Decision on Claritin nothing to sneeze at 
  Hanania NA, Houston Chronicle
  1/9./2002
• Join now to see all